SpheriTech, founded by Don Wellings in 2009 provides consultancy, synthesis, preparative HPLC, contract research and development to a range of industries. we have now installed a 15cm diameter NovaSep DAC, HPLC column. The company is internationally recognized authority on peptide synthesis, oligonucleotide synthesis, polymer particle design and chromatography. The founder is the author of numerous texts and book chapters and is the author of 'A Practical Handbook of Preparative HPLC'. With a track record for innovation he is the main inventor on 17 patents and the sole inventor on all patents filed by SpheriTech to-date. The company has a comprehensive range of equipment including HPLC systems from analytical through to preparative DAC based systems and specializes in contract purification of any molecule, be it small organic or complex protein. With decades of experience in biomolecule manufacture across the team Spheritech can perform complex solid phase synthesis of peptides and oligonucleotides in reactor volumes ranging from millilitres to multi-litre scale. The company has an extensive R&D program currently developing novel inexpensive technologies for the manufacture of polymer particles for applications in solid phase peptide and oligonucleotides synthesis, enzyme immobilization, affinity chromatography and transition metal catalysis. The R&D program also involves the development of novel macroporous polymer networks for cell culture with a particular focus on 3D stem cell culture and differentiation. The company is currently developing a new range of wound dressings based upon a proprietary biopolymer. The senior management team of SpheriTech has a total of 50 years of experience in cGMP manufacture and over 150 combined years’ experience in peptide synthesis. The Company provides consulting services related to process scale needs. SpheriTech also has a broad range of intellectual property covering a diverse platform of technologies.